Prot# VMDN-001: A Phase I/II Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients with Painful Diabetic Peripheral Neuropathy

Project: Research project

Project Details

StatusFinished
Effective start/end date2/22/10 → 2/21/13

Funding

  • ViroMed Co., Ltd. (VMDN-001)